Item talk:Q139454
From geokb
{
"OpenAlex": {
"id": "https://openalex.org/A5061167455",
"orcid": "https://orcid.org/0000-0002-2179-2436",
"display_name": "Lawrence Corey",
"display_name_alternatives": [
"Corey Lawrence",
"L. Corey",
"Larry Corey",
"Lawrence J. Corey",
"Lawrence. Corey"
],
"works_count": 1234,
"cited_by_count": 104750,
"summary_stats": {
"2yr_mean_citedness": 37.989010989010985,
"h_index": 159,
"i10_index": 817
},
"ids": {
"openalex": "https://openalex.org/A5061167455",
"orcid": "https://orcid.org/0000-0002-2179-2436",
"scopus": "http://www.scopus.com/inward/authorDetails.url?authorID=57188630168&partnerID=MN8TOARS"
},
"affiliations": [
{
"institution": {
"id": "https://openalex.org/I4210089486",
"ror": "https://ror.org/007ps6h72",
"display_name": "Fred Hutch Cancer Center",
"country_code": "US",
"type": "nonprofit",
"lineage": [
"https://openalex.org/I4210089486"
]
},
"years": [
2024,
2023,
2022,
2021,
2020,
2019,
2018,
2017,
2016,
2015
]
},
{
"institution": {
"id": "https://openalex.org/I201448701",
"ror": "https://ror.org/00cvxb145",
"display_name": "University of Washington",
"country_code": "US",
"type": "education",
"lineage": [
"https://openalex.org/I201448701"
]
},
"years": [
2024,
2023,
2022,
2021,
2020,
2019,
2018,
2017,
2016,
2015
]
},
{
"institution": {
"id": "https://openalex.org/I4210134534",
"ror": "https://ror.org/043z4tv69",
"display_name": "National Institute of Allergy and Infectious Diseases",
"country_code": "US",
"type": "facility",
"lineage": [
"https://openalex.org/I1299022934",
"https://openalex.org/I1299303238",
"https://openalex.org/I4210134534"
]
},
"years": [
2024,
2021,
1998,
1997,
1994,
1991
]
},
{
"institution": {
"id": "https://openalex.org/I4210140301",
"ror": "https://ror.org/03hgnab62",
"display_name": "Meridian Clinical Research",
"country_code": "US",
"type": "facility",
"lineage": [
"https://openalex.org/I4210140301"
]
},
"years": [
2024,
2021
]
},
{
"institution": {
"id": "https://openalex.org/I4210108601",
"ror": "https://ror.org/01xm4wg91",
"display_name": "Moderna Therapeutics (United States)",
"country_code": "US",
"type": "company",
"lineage": [
"https://openalex.org/I4210108601"
]
},
"years": [
2024
]
},
{
"institution": {
"id": "https://openalex.org/I4210101542",
"ror": "https://ror.org/0185yec04",
"display_name": "Benchmark Research (United States)",
"country_code": "US",
"type": "company",
"lineage": [
"https://openalex.org/I4210101542"
]
},
"years": [
2024
]
},
{
"institution": {
"id": "https://openalex.org/I4210138040",
"ror": "https://ror.org/04nh35860",
"display_name": "Velocity Clinical Research (United States)",
"country_code": "US",
"type": "company",
"lineage": [
"https://openalex.org/I4210138040"
]
},
"years": [
2024
]
},
{
"institution": {
"id": "https://openalex.org/I126744593",
"ror": "https://ror.org/04rq5mt64",
"display_name": "University of Maryland, Baltimore",
"country_code": "US",
"type": "education",
"lineage": [
"https://openalex.org/I126744593"
]
},
"years": [
2024,
2021
]
},
{
"institution": {
"id": "https://openalex.org/I181547552",
"ror": "https://ror.org/02pttbw34",
"display_name": "Baylor College of Medicine",
"country_code": "US",
"type": "education",
"lineage": [
"https://openalex.org/I181547552",
"https://openalex.org/I2801539370"
]
},
"years": [
2024
]
},
{
"institution": {
"id": "https://openalex.org/I4210127473",
"ror": "https://ror.org/03fbwjm33",
"display_name": "Cancer Research Center",
"country_code": "US",
"type": "nonprofit",
"lineage": [
"https://openalex.org/I4210127473"
]
},
"years": [
2023,
2022,
2021,
2020,
2019,
2018,
2017,
2016,
2015,
2014
]
}
],
"last_known_institutions": [
{
"id": "https://openalex.org/I4210089486",
"ror": "https://ror.org/007ps6h72",
"display_name": "Fred Hutch Cancer Center",
"country_code": "US",
"type": "nonprofit",
"lineage": [
"https://openalex.org/I4210089486"
]
}
],
"topics": [
{
"id": "https://openalex.org/T10625",
"display_name": "Herpesviruses: Epidemiology, Pathogenesis, and Management",
"count": 102,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10981",
"display_name": "Epidemiology and Management of Cytomegalovirus Infection",
"count": 101,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10112",
"display_name": "Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome",
"count": 75,
"subfield": {
"id": "https://openalex.org/subfields/2406",
"display_name": "Virology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10082",
"display_name": "Prevention and Treatment of HIV/AIDS Infection",
"count": 34,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12849",
"display_name": "Parvovirus B19 Infection and Pathogenesis",
"count": 32,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11020",
"display_name": "Natural Killer Cells in Immunity",
"count": 31,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10526",
"display_name": "Efficacy and Safety of Antiretroviral Therapy for HIV",
"count": 30,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11243",
"display_name": "Epidemiology and Pathogenesis of Respiratory Viral Infections",
"count": 30,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10151",
"display_name": "Hepatitis C Infection and Treatment",
"count": 27,
"subfield": {
"id": "https://openalex.org/subfields/2721",
"display_name": "Hepatology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10613",
"display_name": "Gene Therapy Techniques and Applications",
"count": 27,
"subfield": {
"id": "https://openalex.org/subfields/1311",
"display_name": "Genetics"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10685",
"display_name": "Viral-Related Cancers in Immunocompromised Patients",
"count": 24,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10340",
"display_name": "Hepatitis B Infection and Treatment",
"count": 23,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10118",
"display_name": "Coronavirus Disease 2019 Research",
"count": 20,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12576",
"display_name": "Prediction of Peptide-MHC Binding Affinity",
"count": 19,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10345",
"display_name": "Hematopoietic Stem Cell Biology",
"count": 18,
"subfield": {
"id": "https://openalex.org/subfields/2720",
"display_name": "Hematology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10580",
"display_name": "Immunobiology of Dendritic Cells",
"count": 17,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11827",
"display_name": "Polyomavirus-Associated Carcinogenesis and Clinical Manifestations",
"count": 14,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10833",
"display_name": "Factors Affecting Vaccine Hesitancy and Acceptance",
"count": 12,
"subfield": {
"id": "https://openalex.org/subfields/3306",
"display_name": "Health"
},
"field": {
"id": "https://openalex.org/fields/33",
"display_name": "Social Sciences"
},
"domain": {
"id": "https://openalex.org/domains/2",
"display_name": "Social Sciences"
}
},
{
"id": "https://openalex.org/T10167",
"display_name": "Influenza Virus Research and Epidemiology",
"count": 12,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10150",
"display_name": "Diagnosis and Management of Fungal Infections",
"count": 11,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10308",
"display_name": "Systemic Lupus Erythematosus and Antiphospholipid Syndrome",
"count": 11,
"subfield": {
"id": "https://openalex.org/subfields/2745",
"display_name": "Rheumatology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10976",
"display_name": "Gastrointestinal Viral Infections and Vaccines Development",
"count": 11,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10041",
"display_name": "Coronavirus Disease 2019",
"count": 10,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10031",
"display_name": "Regulatory T Cell Development and Function",
"count": 10,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11037",
"display_name": "Epidemiology and Management of Fungal Infections",
"count": 9,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
}
],
"topic_share": [
{
"id": "https://openalex.org/T10981",
"display_name": "Epidemiology and Management of Cytomegalovirus Infection",
"value": 0.0004775,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10625",
"display_name": "Herpesviruses: Epidemiology, Pathogenesis, and Management",
"value": 0.0004249,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10112",
"display_name": "Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome",
"value": 0.0003448,
"subfield": {
"id": "https://openalex.org/subfields/2406",
"display_name": "Virology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T12849",
"display_name": "Parvovirus B19 Infection and Pathogenesis",
"value": 0.000298,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T12576",
"display_name": "Prediction of Peptide-MHC Binding Affinity",
"value": 0.0002725,
"subfield": {
"id": "https://openalex.org/subfields/1312",
"display_name": "Molecular Biology"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10685",
"display_name": "Viral-Related Cancers in Immunocompromised Patients",
"value": 0.000192,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10526",
"display_name": "Efficacy and Safety of Antiretroviral Therapy for HIV",
"value": 0.0001658,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11827",
"display_name": "Polyomavirus-Associated Carcinogenesis and Clinical Manifestations",
"value": 0.0001445,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11243",
"display_name": "Epidemiology and Pathogenesis of Respiratory Viral Infections",
"value": 0.0001424,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10345",
"display_name": "Hematopoietic Stem Cell Biology",
"value": 0.0001392,
"subfield": {
"id": "https://openalex.org/subfields/2720",
"display_name": "Hematology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10082",
"display_name": "Prevention and Treatment of HIV/AIDS Infection",
"value": 0.0001382,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10151",
"display_name": "Hepatitis C Infection and Treatment",
"value": 0.0001047,
"subfield": {
"id": "https://openalex.org/subfields/2721",
"display_name": "Hepatology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11754",
"display_name": "Diagnostic Methods for COVID-19 Detection",
"value": 0.0001018,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11655",
"display_name": "Impact of HIV Infection on Cardiovascular Health",
"value": 9.81e-05,
"subfield": {
"id": "https://openalex.org/subfields/2711",
"display_name": "Emergency Medicine"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10118",
"display_name": "Coronavirus Disease 2019 Research",
"value": 9.8e-05,
"subfield": {
"id": "https://openalex.org/subfields/2725",
"display_name": "Infectious Diseases"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11767",
"display_name": "Epidemiology and Pathobiology of Monkeypox Virus Infection",
"value": "9e-05",
"subfield": {
"id": "https://openalex.org/subfields/2406",
"display_name": "Virology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10613",
"display_name": "Gene Therapy Techniques and Applications",
"value": 8.82e-05,
"subfield": {
"id": "https://openalex.org/subfields/1311",
"display_name": "Genetics"
},
"field": {
"id": "https://openalex.org/fields/13",
"display_name": "Biochemistry, Genetics and Molecular Biology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T12172",
"display_name": "Management of Febrile Neutropenia in Cancer Patients",
"value": 8.75e-05,
"subfield": {
"id": "https://openalex.org/subfields/2730",
"display_name": "Oncology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T11155",
"display_name": "Toxoplasmosis and Neosporosis Research",
"value": 8.72e-05,
"subfield": {
"id": "https://openalex.org/subfields/2405",
"display_name": "Parasitology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T11934",
"display_name": "Biological Basis and Clinical Management of Syphilis",
"value": 7.79e-05,
"subfield": {
"id": "https://openalex.org/subfields/2737",
"display_name": "Physiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10340",
"display_name": "Hepatitis B Infection and Treatment",
"value": 7.72e-05,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10833",
"display_name": "Factors Affecting Vaccine Hesitancy and Acceptance",
"value": 7.14e-05,
"subfield": {
"id": "https://openalex.org/subfields/3306",
"display_name": "Health"
},
"field": {
"id": "https://openalex.org/fields/33",
"display_name": "Social Sciences"
},
"domain": {
"id": "https://openalex.org/domains/2",
"display_name": "Social Sciences"
}
},
{
"id": "https://openalex.org/T11020",
"display_name": "Natural Killer Cells in Immunity",
"value": 7.1e-05,
"subfield": {
"id": "https://openalex.org/subfields/2403",
"display_name": "Immunology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
},
{
"id": "https://openalex.org/T10167",
"display_name": "Influenza Virus Research and Epidemiology",
"value": 6.87e-05,
"subfield": {
"id": "https://openalex.org/subfields/2713",
"display_name": "Epidemiology"
},
"field": {
"id": "https://openalex.org/fields/27",
"display_name": "Medicine"
},
"domain": {
"id": "https://openalex.org/domains/4",
"display_name": "Health Sciences"
}
},
{
"id": "https://openalex.org/T10428",
"display_name": "Vaginal Microbiome and Sexually Transmitted Infections",
"value": 6.74e-05,
"subfield": {
"id": "https://openalex.org/subfields/2404",
"display_name": "Microbiology"
},
"field": {
"id": "https://openalex.org/fields/24",
"display_name": "Immunology and Microbiology"
},
"domain": {
"id": "https://openalex.org/domains/1",
"display_name": "Life Sciences"
}
}
],
"x_concepts": [
{
"id": "https://openalex.org/C71924100",
"wikidata": "https://www.wikidata.org/wiki/Q11190",
"display_name": "Medicine",
"level": 0,
"score": 100.9
},
{
"id": "https://openalex.org/C86803240",
"wikidata": "https://www.wikidata.org/wiki/Q420",
"display_name": "Biology",
"level": 0,
"score": 97.4
},
{
"id": "https://openalex.org/C203014093",
"wikidata": "https://www.wikidata.org/wiki/Q101929",
"display_name": "Immunology",
"level": 1,
"score": 90.7
},
{
"id": "https://openalex.org/C159047783",
"wikidata": "https://www.wikidata.org/wiki/Q7215",
"display_name": "Virology",
"level": 1,
"score": 89.3
},
{
"id": "https://openalex.org/C54355233",
"wikidata": "https://www.wikidata.org/wiki/Q7162",
"display_name": "Genetics",
"level": 1,
"score": 87.7
},
{
"id": "https://openalex.org/C126322002",
"wikidata": "https://www.wikidata.org/wiki/Q11180",
"display_name": "Internal medicine",
"level": 1,
"score": 67.7
},
{
"id": "https://openalex.org/C2522874641",
"wikidata": "https://www.wikidata.org/wiki/Q808",
"display_name": "Virus",
"level": 2,
"score": 66.6
},
{
"id": "https://openalex.org/C142724271",
"wikidata": "https://www.wikidata.org/wiki/Q7208",
"display_name": "Pathology",
"level": 1,
"score": 57.9
},
{
"id": "https://openalex.org/C512399662",
"wikidata": "https://www.wikidata.org/wiki/Q3505712",
"display_name": "Family medicine",
"level": 1,
"score": 55.3
},
{
"id": "https://openalex.org/C3013748606",
"wikidata": "https://www.wikidata.org/wiki/Q15787",
"display_name": "Human immunodeficiency virus (HIV)",
"level": 2,
"score": 53.4
},
{
"id": "https://openalex.org/C159654299",
"wikidata": "https://www.wikidata.org/wiki/Q79460",
"display_name": "Antibody",
"level": 2,
"score": 43.6
},
{
"id": "https://openalex.org/C185592680",
"wikidata": "https://www.wikidata.org/wiki/Q2329",
"display_name": "Chemistry",
"level": 0,
"score": 39.8
},
{
"id": "https://openalex.org/C55493867",
"wikidata": "https://www.wikidata.org/wiki/Q7094",
"display_name": "Biochemistry",
"level": 1,
"score": 36.8
},
{
"id": "https://openalex.org/C141071460",
"wikidata": "https://www.wikidata.org/wiki/Q40821",
"display_name": "Surgery",
"level": 1,
"score": 31.0
},
{
"id": "https://openalex.org/C2781196997",
"wikidata": "https://www.wikidata.org/wiki/Q655331",
"display_name": "Herpes simplex virus",
"level": 3,
"score": 30.7
},
{
"id": "https://openalex.org/C8891405",
"wikidata": "https://www.wikidata.org/wiki/Q1059",
"display_name": "Immune system",
"level": 2,
"score": 28.7
},
{
"id": "https://openalex.org/C2780727368",
"wikidata": "https://www.wikidata.org/wiki/Q1928978",
"display_name": "Viral disease",
"level": 3,
"score": 23.3
},
{
"id": "https://openalex.org/C104317684",
"wikidata": "https://www.wikidata.org/wiki/Q7187",
"display_name": "Gene",
"level": 2,
"score": 22.6
}
],
"counts_by_year": [
{
"year": 2024,
"works_count": 34,
"cited_by_count": 6714
},
{
"year": 2023,
"works_count": 46,
"cited_by_count": 13208
},
{
"year": 2022,
"works_count": 38,
"cited_by_count": 18606
},
{
"year": 2021,
"works_count": 53,
"cited_by_count": 16078
},
{
"year": 2020,
"works_count": 45,
"cited_by_count": 6636
},
{
"year": 2019,
"works_count": 21,
"cited_by_count": 5882
},
{
"year": 2018,
"works_count": 15,
"cited_by_count": 5846
},
{
"year": 2017,
"works_count": 25,
"cited_by_count": 6432
},
{
"year": 2016,
"works_count": 28,
"cited_by_count": 7697
},
{
"year": 2015,
"works_count": 22,
"cited_by_count": 7618
},
{
"year": 2014,
"works_count": 15,
"cited_by_count": 9067
},
{
"year": 2013,
"works_count": 20,
"cited_by_count": 8436
},
{
"year": 2012,
"works_count": 24,
"cited_by_count": 8799
}
],
"works_api_url": "https://api.openalex.org/works?filter=author.id:A5061167455",
"updated_date": "2024-08-27T01:05:19.956858",
"created_date": "2023-07-21",
"_id": "https://openalex.org/A5061167455"
},
"ORCID": {
"@context": "http://schema.org",
"@type": "Person",
"@id": "https://orcid.org/0000-0002-2179-2436",
"mainEntityOfPage": "https://orcid.org/0000-0002-2179-2436",
"givenName": "Lawrence",
"familyName": "Corey",
"alumniOf": {
"@type": "Organization",
"name": "University of Michigan",
"identifier": {
"@type": "PropertyValue",
"propertyID": "RINGGOLD",
"value": "1259"
}
},
"affiliation": [
{
"@type": "Organization",
"@id": "grid.270240.3",
"name": "Fred Hutchinson Cancer Research Center"
},
{
"@type": "Organization",
"name": "University of Washington",
"identifier": {
"@type": "PropertyValue",
"propertyID": "RINGGOLD",
"value": "7284"
}
}
],
"@reverse": {
"creator": [
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1097/olq.0000000000002030",
"name": "Reflections on Progress in Genital Herpes Therapy and Prevention 1997 to 2024",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1097/olq.0000000000002030"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jia2.26257",
"name": "The potential of broadly neutralizing antibodies for HIV prevention",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jia2.26257"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jia2.26118",
"name": "Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jia2.26118"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1016/j.omtm.2022.11.004",
"name": "Novel engineered chimeric engulfment receptors trigger T\u00a0cell effector functions against SIV-infected CD4+ T\u00a0cells",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1016/j.omtm.2022.11.004"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1038/s41541-022-00535-4",
"name": "KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1038/s41541-022-00535-4"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1172/jci160565",
"name": "Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1172/jci160565"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.7326/m22-1300",
"name": "Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.7326/m22-1300"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejmoa2105290",
"name": "Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejmoa2105290"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/jiab267",
"name": "Behind the Scenes Heroes: The COVID-19 Vaccine Data and Safety Monitoring Board",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/jiab267"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jia2.25829",
"name": "Broadly neutralizing monoclonal antibodies for HIV prevention",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jia2.25829"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1038/s41586-021-03792-w",
"name": "After the pandemic: perspectives on the future trajectory of COVID-19",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1038/s41586-021-03792-w"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejmsb2104756",
"name": "SARS-CoV-2 Variants in Patients with Immunosuppression",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejmsb2104756"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1371/journal.pcbi.1009072",
"name": "Examining the dynamics of Epstein-Barr virus shedding in the tonsils and the impact of HIV-1 coinfection on daily saliva viral loads",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1371/journal.pcbi.1009072"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jia2.25749",
"name": "The path to find an HIV vaccine",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jia2.25749"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejmoa2031738",
"name": "Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejmoa2031738"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1126/scitranslmed.abe0948",
"name": "Prospects for a safe COVID-19 vaccine",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1126/scitranslmed.abe0948"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1101/2020.08.21.260935",
"name": "A CAR RNA FISH assay to study functional and spatial heterogeneity of chimeric antigen receptor T cells in tissue",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1101/2020.08.21.260935"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1172/jci132583",
"name": "Tissue-resident T cell\u2013derived cytokines eliminate herpes simplex virus-2\u2013infected cells",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1172/jci132583"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1128/jvi.01574-18",
"name": "Acute infection and subsequent subclinical reactivation of herpes simplex virus 2 after vaginal inoculation of rhesus macaques",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85059496411"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1128/jvi.01574-18"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1038/s41598-019-39962-0",
"name": "Random-Reaction-Seed Method for Automated Identification of Neurite Elongation and Branching",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85062214755"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1038/s41598-019-39962-0"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jia2.25289",
"name": "The aspirational necessity of HIV prevention",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jia2.25289"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85066799636"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.4049/jimmunol.1800471",
"name": "A fixed spatial structure of CD8 + T cells in tissue during chronic HSV-2 Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85052451170"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.4049/jimmunol.1800471"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/jiy372",
"name": "Herpes simplex virus shedding rate: Surrogate outcome for genital herpes recurrence frequency and lesion rates, and phase 2 clinical trials end point for evaluating efficacy of antivirals",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85055171896"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/jiy372"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1097/qad.0000000000002002",
"name": "Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85055844959"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1097/qad.0000000000002002"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.3133/fs20183002",
"name": "Landscapes from the waves\u2014Marine terraces of California",
"identifier": {
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.3133/fs20183002"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1097/inf.0000000000001877",
"name": "Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1097/inf.0000000000001877"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85050138893"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1136/sextrans-2017-053244",
"name": "Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85049115557"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1136/sextrans-2017-053244"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1016/s2352-3018(18)30071-7",
"name": "Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1016/s2352-3018(18)30071-7"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85048155729"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1089/aid.2018.0031",
"name": "Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85051067944"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1089/aid.2018.0031"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/jix360",
"name": "Adoptive Immunotherapy of Viral Infections: Should Infectious Disease Embrace Cellular Immunotherapy?",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85040218180"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/jix360"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1371/journal.pone.0176428",
"name": "Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1371/journal.pone.0176428"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85019165739"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1126/science.aap8131",
"name": "Broadly neutralizing antibodies to prevent HIV-1",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85030629028"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1126/science.aap8131"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/jix048",
"name": "Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid from Hematopoietic Stem Cell Transplant Recipients with CMV Pneumonia",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/jix048"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85020208570"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1128/cvi.00263-17",
"name": "DNA priming increases frequency of T-cell responses to a vesicular stomatitis virus HIV vaccine with specific enhancement of CD8 T-cell responses by interleukin-12 plasmid DNA",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85036527098"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1128/cvi.00263-17"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1038/mi.2016.118",
"name": "Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85027981382"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1038/mi.2016.118"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/jix086",
"name": "Higher T-Cell responses induced by DNA/rAd5 HIV-1 preventive vaccine are associated with lower HIV-1 infection risk in an efficacy trial",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85021890119"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/jix086"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1084/jem.20160581",
"name": "Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1084/jem.20160581"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85027351215"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1080/19420862.2017.1311435",
"name": "Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85019570515"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1080/19420862.2017.1311435"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1073/pnas.1703236114",
"name": "Preventing acquisition of HIV is the only path to an AIDS-free generation",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85035066869"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1073/pnas.1703236114"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1371/journal.pmed.1002435",
"name": "Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85036569550"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1371/journal.pmed.1002435"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1371/journal.pone.0185959",
"name": "Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1371/journal.pone.0185959"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85034248781"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1128/jvi.00380-17",
"name": "Transient oral human cytomegalovirus infections indicate inefficient viral spread from very few initially infected cells",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1128/jvi.00380-17"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85019667133"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/jix263",
"name": "Valganciclovir for the suppression of Epstein-Barr virus replication",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85028445931"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/jix263"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1038/s41598-017-12994-0",
"name": "Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85031302079"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1038/s41598-017-12994-0"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1016/j.vaccine.2016.09.054",
"name": "A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1016/j.vaccine.2016.09.054"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-84992616421"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/jiw442",
"name": "Dynamics of persistent oral cytomegalovirus shedding during primary infection in ugandan infants",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/jiw442"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85014712022"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1001/jama.2016.18189",
"name": "Effect of pritelivir compared with valacyclovir on genital HSV-2 shedding in patients with frequent recurrences: A randomized clinical trial",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85008225359"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1001/jama.2016.18189"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1097/olq.0000000000000522",
"name": "Herpes simplex virus type 1 shedding in tears and nasal and oral mucosa of healthy adults",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1097/olq.0000000000000522"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-84992052005"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1371/journal.pone.0161753",
"name": "Sequential immunization with GP140 boosts immune responses primed by modified vaccinia Ankara or DNA in HIV-uninfected South African participants",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-84991242144"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1371/journal.pone.0161753"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/cid/civ908",
"name": "Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/cid/civ908"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-84983113151"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1097/qai.0b013e31821acb5",
"name": "Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the step study)",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85027927845"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1097/qai.0b013e31821acb5"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1097/01.aog.0000199416.92484.94",
"name": "Genital herpes complicating pregnancy",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85026158305"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1097/01.aog.0000199416.92484.94"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1001/jama.289.2.203",
"name": "Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1001/jama.289.2.203"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0037425558"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/339605",
"name": "Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0036534816"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/339605"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/338044",
"name": "Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0036467246"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/338044"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/339202",
"name": "Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0036532203"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/339202"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/342969",
"name": "Genital shedding of herpes simplex virus among men",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/342969"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0037108420"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/338624",
"name": "High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: Evidence for indirect effects of primary CMV infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/338624"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0036467791"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/341774",
"name": "Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0036720454"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/341774"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/338116",
"name": "Search for polymorphisms in the genes for herpesvirus entry mediator, nectin-1, and nectin-2 in immune seronegative individuals",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0036138442"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/338116"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/339325",
"name": "Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0036532218"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/339325"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/318089",
"name": "Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/318089"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0035253438"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/322654",
"name": "Herpes simplex virus shedding and plasma human immunodeficiency virus RNA levels in coinfected women",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0035884752"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/322654"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/322642",
"name": "Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0035885050"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/322642"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/324003",
"name": "Long-Term Entecavir Treatment Results in Sustained Antiviral Efficacy and Prolonged Life Span in the Woodchuck Model of Chronic Hepatitis Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/324003"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0035890097"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/322043",
"name": "Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0035426018"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/322043"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/318524",
"name": "Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/318524"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0035865791"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/319863",
"name": "Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0035341521"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/319863"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/320189",
"name": "Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0035873685"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/320189"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/318447",
"name": "Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/318447"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0035245331"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/315749",
"name": "Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/315749"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0033823579"
}
]
},
{
"@type": "CreativeWork",
"name": "Immunologic strategies for herpes vaccination",
"identifier": {
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0034624390"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1086/315753",
"name": "Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0033823552"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1086/315753"
}
]
},
{
"@type": "CreativeWork",
"name": "Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes",
"identifier": {
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0029891259"
}
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1155/s1064744996000038",
"name": "Cervical Antibodies to Herpes Simplex Virus Proteins in Pregnancy and Puerperium: A Pilot Study",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-84958731643"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1155/s1064744996000038"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1016/0002-9378(95)91496-x",
"name": "A comparison of between detailed and simple histories in the diagnosis of genital herpes complicating pregnancy",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1016/0002-9378(95)91496-x"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0028899308"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199509213331205",
"name": "Virologic characteristics of subclinical and symptomatic genital herpes infections",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199509213331205"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0029135197"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1089/aid.1994.10.551",
"name": "Analysis of Cytotoxic T Lymphocyte Responses to SIV Proteins in SIV-Infected Macaques Using Antigen-Specific Stimulation with Recombinant Vaccinia and Fowl Poxviruses",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0028360649"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1089/aid.1994.10.551"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1136/bmj.309.6965.1325",
"name": "Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1136/bmj.309.6965.1325"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0028172131"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1089/aid.1994.10.541",
"name": "HIV-Infected Macrophages as Efficient Stimulator Cells for Detection of Cytotoxic T Cell Responses to HIV in Seronegative and Seropositive Vaccine Recipients",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1089/aid.1994.10.541"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0028105453"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1089/aid.1994.10.1713",
"name": "Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0028670689"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1089/aid.1994.10.1713"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1016/0190-9622(93)70064-z",
"name": "Dual infection with human papillomavirus in a population with overt genital condylomas",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0027397683"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1016/0190-9622(93)70064-z"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jmv.1890410504",
"name": "Herpes simplex virus infections during the decade since the licensure of acyclovir",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jmv.1890410504"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0027722722"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199307153290302",
"name": "Human Herpesvirus 6 in Lung Tissue from Patients with Pneumonitis after Bone Marrow Transplantation",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199307153290302"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0027238607"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/168.1.38",
"name": "Penile Intraepithelial Neoplasia: Clinical Presentation and an Analysis of the Physical State of Human Papillomavirus DNA",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/168.1.38"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0027231369"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jmv.1890410528",
"name": "Potential for combined therapy with 348u87, a ribonucleotide reductase inhibitor, and acyclovir as treatment for acyclovir\u2010resistant herpes simplex virus infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jmv.1890410528"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0027734069"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199312093292416",
"name": "Primary Human Herpesvirus 6 Infection in an Adult",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0027913151"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199312093292416"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/168.6.1387",
"name": "Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0027430975"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/168.6.1387"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1089/aid.1992.8.581",
"name": "A Randomized, Double-Blind, Phase I/II Trial of Tumor Necrosis Factor and Interferon-Gamma for Treatment of AIDS-Related Complex (Protocol 025 from the AIDS Clinical Trials Group)",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1089/aid.1992.8.581"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0026994504"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1089/hum.1992.3.3-319",
"name": "Phase I Study of Cellular Adoptive Immunotherapy using Genetically Modified CD8 + HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1089/hum.1992.3.3-319"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0026871222"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199202133260710",
"name": "Treatment of HIV Infection \u2014 progress in perspective",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0026518677"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199202133260710"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199206043262305",
"name": "Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199206043262305"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0026724898"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199102143240703",
"name": "A Controlled Trial Comparing Vidarabine with Acyclovir in Neonatal Herpes Simplex Virus Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0026100403"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199102143240703"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199104043241414",
"name": "A reduced dose of zidovudine in patients with AIDS",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199104043241414"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0025828521"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199109263251314",
"name": "Neonatal herpes simplex virus infection and asymptomatic maternal infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199109263251314"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0025943228"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199105023241804",
"name": "Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199105023241804"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0025845506"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1016/s0002-9378(11)80023-2",
"name": "Pharmacokinetics of acyclovir in the term human pregnancy and neonate",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1016/s0002-9378(11)80023-2"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0026031415"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199102143240704",
"name": "Predictors of morbidity and mortality in neonates with herpes simplex virus infections",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0025978791"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199102143240704"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199010113231502",
"name": "A Pilot Study of Low-Dose Zidovudine in Human Immunodeficiency Virus Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199010113231502"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0025053184"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199005173222013",
"name": "Quantitation of human immunodeficiency virus in the blood",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199005173222013"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0025347197"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199003153221101",
"name": "Sexually transmitted diseases in victims of rape",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199003153221101"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0025306272"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm199004053221401",
"name": "Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection: A Controlled Trial in Persons with Fewer Than 500 CD4-Positive Cells per Cubic Millimeter",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0025238899"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm199004053221401"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198912143212402",
"name": "Plasma Viremia in Human Immunodeficiency Virus Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0024820891"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198912143212402"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jmv.1890250214",
"name": "Analysis of a major target of the human immune response to cytomegalovirus using monoclonal antibodies",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jmv.1890250214"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0023899075"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jmv.1890240308",
"name": "Differential effect of systemic acyclovir treatment of genital HSV\u20102 infections on antibody responses to individual HSV\u20102 proteins",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0023928125"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jmv.1890240308"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1016/s0190-9622(88)70020-1",
"name": "First-episode, recurrent, and asymptomatic herpes simplex infections",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1016/s0190-9622(88)70020-1"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0023830660"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1016/s0190-9622(88)80004-5",
"name": "Questions and answers",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1016/s0190-9622(88)80004-5"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-85025519130"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198804143181511",
"name": "Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal Cancer",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198804143181511"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0023910099"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198711123172002",
"name": "Effects on Infants of a First Episode of Genital Herpes during Pregnancy",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0023203258"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198711123172002"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198703193161216",
"name": "Herpes Simplex Virus Infections",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0023158533"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198703193161216"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198706043162304",
"name": "Recurrences after Oral and Genital Herpes Simplex Virus Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198706043162304"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0023226177"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198710153171601",
"name": "Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal Cancer",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0023276540"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198710153171601"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198603133141105",
"name": "Infections with Herpes Simplex Viruses",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0022646583"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198603133141105"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198603203141205",
"name": "Infections with Herpes Simplex Viruses",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198603203141205"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0022618352"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1016/s0732-8893(86)80049-9",
"name": "Laboratory diagnosis of herpes simplex virus infections: Principles guiding the development of rapid diagnostic tests",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1016/s0732-8893(86)80049-9"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0022544366"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198502283120901",
"name": "Adenovirus Infections in Patients Undergoing Bone-Marrow Transplantation",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0021930668"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198502283120901"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198506273122614",
"name": "Fulminant Liver Failure Induced by Adenovirus after Bone Marrow Transplantation",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198506273122614"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0021879282"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1002/jmv.1890170208",
"name": "Humoral immune response to HSV\u20101 and HSV\u20102 viral proteins in patients with primary genital herpes",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1002/jmv.1890170208"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0022402592"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198406143102402",
"name": "A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198406143102402"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0021275181"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1093/infdis/150.1.1",
"name": "A collaborative study of patients-initiated treatment of recurrent genital herpes with topical acyclovir or placebo",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1093/infdis/150.1.1"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0021287955"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198304143081503",
"name": "Herpes Simplex Virus Proctitis in Homosexual Men: Clinical, Sigmoidoscopic, and Histopathological Features",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0020632340"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198304143081503"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198311033091815",
"name": "Mechanism of Genitourinary Symptoms in Herpes Simplex Virus Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198311033091815"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0020629225"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198309083091002",
"name": "The Polymicrobial Origin of Intestinal Infections in Homosexual Men",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0020629623"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198309083091002"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198206033062201",
"name": "A Trial of Topical Acyclovir in Genital Herpes Simplex Virus Infections",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198206033062201"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0020053283"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198211043071911",
"name": "Topical Acyclovir for Genital Herpes",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198211043071911"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0019977771"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198112243052616",
"name": "Recurrent Genital Herpes: Reinfection or Reactivation?",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0019887638"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198112243052616"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198108063050604",
"name": "Risk of Recurrence after First Episodes of Genital Herpes: Relation to HSV Type and Antibody Response",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0019521035"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198108063050604"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198009183031219",
"name": "Atypical Generalized Zoster with Lymphadenitis Mimicking Lymphoma",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0019328127"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198009183031219"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198004103021507",
"name": "Atypical Generalized Zoster with Lymphadenitis Mimicking Lymphoma",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0019224175"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198004103021507"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198007313030514",
"name": "Sexual Transmission of Hepatitis A in Homosexual Men",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198007313030514"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0019336695"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm198002213020804",
"name": "Sexual Transmission of Hepatitis A in Homosexual Men: Incidence and Mechanism",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0018864442"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm198002213020804"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm197811022991805",
"name": "Cellular Immune Response in Genital Herpes Simplex Virus Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0018133887"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm197811022991805"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm197808032990507",
"name": "Ineffectiveness of Topical Ether for the Treatment of Genital Herpes Simplex Virus Infection",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm197808032990507"
},
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0018194114"
}
]
},
{
"@type": "CreativeWork",
"@id": "https://doi.org/10.1056/nejm197512182932501",
"name": "Hb<inf>S</inf>Ag-Negative Hepatitis in a Hemodialysis Unit Relation to Epstein\u2013Barr Virus",
"identifier": [
{
"@type": "PropertyValue",
"propertyID": "eid",
"value": "2-s2.0-0016589719"
},
{
"@type": "PropertyValue",
"propertyID": "doi",
"value": "10.1056/nejm197512182932501"
}
]
}
]
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "Scopus Author ID",
"value": "57188630168"
}
}
}
